PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease Reportsmusculoskeletal pain
MeSH D059352 - musculoskeletal pain
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D010146:Pain
306 Companies
110 Drugs
$
Success rate
D009135:Muscular diseases
0 Companies
0 Drugs
Success rate
D012677:Sensation
0 Companies
0 Drugs
Success rate
D059352: 
Musculoskeletal pain
26 Companies
1 Drug
$
Success rate
D059388:Pelvic girdle pain
0 Companies
0 Drugs
Success rate
D063806:Myalgia
0 Companies
0 Drugs
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
TevaDuloxetine Duloxetine  2013-12-11   
MylanDuloxetine Duloxetine Mylan  2015-06-19   
Lupin ResearchDuloxetine Duloxetine  2013-12-11   
Boehringer IngelheimDuloxetine Duloxetine Boehringer Ingelheim  2008-10-08   
Eli LillyDuloxetine Ariclaim  2004-08-11   
Duloxetine Cymbalta  2004-08-03 $283.3 M Y2022 
Duloxetine Duloxetine Lilly  2014-12-08   
Duloxetine Yentreve  2004-08-11   
Aurobindo PharmaDuloxetine Duloxetine  2013-12-11   
Ajanta PharmaDuloxetine Duloxetine  2017-01-06   
Zydus TherapeuticsDuloxetine Duloxetine  2014-01-08   
Sun Pharmaceutical IndustriesDuloxetine Drizalma 2037-04-13 2019-07-19   
Duloxetine Duloxetine  2013-12-11   
Alembic PharmaceuticalsDuloxetine Duloxetine  2014-06-09   
1
2
3
>
Clinical Trials
Historical Success Rate
Phase 1
71%
5/7
Phase 2
50%
12/24
Phase 3
28%
5/18
Approved: 2Overall Success rate: 10%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Boehringer Ingelheim
Duloxetine
Eli Lilly
Duloxetine
1
2
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use